Projects

Young independent researcher
Mgr. Barbora Kaločayová, PhD.

International

Current
  • Bridging the gap between cardiac and vascular regeneration
    Program: Horizon Europe
    Duration: 1. 1. 2024 – 31. 12. 2026
Finished
  • Biocatalytic development of novel hybrid molecules with improved cardioprotective properties: Targeting the Na+,K+-ATPase
    Program: Inter-governmental agreement
    Duration: 1. 1. 2013 – 31. 12. 2014

National

Current
  • Identification of stress-induced alterations in expression of NRF2 target genes in rat models of prehypertension: the effect of comorbid hypertriglyceridemia and dimethyl fumarate treatment
    Program: SRDA
    Duration: 1. 7. 2023 – 30. 6. 2027
  • Targeted suppression of pro-inflammatory and pro-fibrotic signaling pathways to prevent heart failure and occurrence of malignant arrhythmias
    Program: SRDA
    Duration: 1. 7. 2022 – 30. 6. 2026
  • New aspects of cardioprotection by natural antioxidants: role of ageing and lifestyle-related comorbidities
    Program: SRDA
    Duration: 1. 7. 2022 – 30. 6. 2026
  • New methods of treating heart failure. Prevention of oxidative stress by molecular hydrogen.
    Program: VEGA
    Duration: 1. 1. 2022 – 31. 12. 2025
  • Development of diabetic nephropathy and its treatment with nutraceutic in experimental conditions
    Program: VEGA
    Duration: 1. 1. 2022 – 31. 12. 2025
Finished
  • The role of miRNAs in the onset and progression of cardiovascular diseases - new approach to the protection of the heart in situations of increased production of reactive oxygen species
    Program: SRDA
    Duration: 1. 7. 2020 – 30. 6. 2024
  • Study of new mechanisms of cardioprotection against ischemia-reperfusion injury of the heart: role of extracellular vesicles, non-coding RNAs and impact of metabolic co-morbidities on these mechanisms
    Program: VEGA
    Duration: 1. 1. 2020 – 31. 12. 2023
  • Heart protection in situations of excessive formation of oxygen and nitrosyl radicals: Molecular hydrogen as a new potential therapeutic tool?
    Program: VEGA
    Duration: 1. 1. 2018 – 31. 12. 2021
  • Response of the Na,K-ATPase, representing one of the crucial systems in maintaining the sodium homeostasis, to civilization diseases namely: hypertension, diabetes and hypertriglyceridemia.
    Program: VEGA
    Duration: 1. 1. 2013 – 31. 12. 2016
  • Calcium channels in neuronal excitability
    Program: SRDA
    Duration: 1. 5. 2011 – 31. 10. 2014
Employees